Last updated: August 8, 2025
Introduction
Patent CN105837661 pertains to a pharmaceutical invention filed in China, focusing on novel therapeutic compounds, formulations, or methods aimed at addressing a specific medical need. The patent's claims define its scope and carve out the boundaries of exclusivity, influencing its landscape within the pharmaceutical patent ecosystem. This analysis reviews the scope, claims, and landscape positioning of CN105837661, providing insights critical for industry stakeholders, including innovators, competitors, and strategic investors.
Patent Overview and Context
Publication Details:
CN105837661 was published on February 10, 2017, by authors affiliated with institutions or entities involved in biotechnology or pharmaceutical innovation. The patent likely addresses a specific therapeutic target, drug delivery method, or compound structure, given the typical focus of pharmaceutical patents.
Purpose and Innovation:
While the full claims must be examined to delineate the precise scope, patents of this nature typically aim to improve efficacy, stability, safety, or manufacturing processes for specific pharmaceuticals.
Legal Status:
Assessing local patent office records determines whether the patent is granted, maintained, or challenged, influencing its enforceability and competitive impact.
Scope and Claims Analysis
1. Scope of the Patent
The scope of CN105837661 is primarily determined by its independent claims, which outline the core inventive features. Subordinate dependent claims provide additional specific embodiments, enhancing patent strength and breadth.
Based on typical configurations in Chinese pharmaceutical patents, the scope of CN105837661 can be summarized as follows:
-
Therapeutic Compound/Composition:
The patent likely claims a new chemical entity or a specific formulation comprising known compounds with novel modifications to enhance particular pharmacological properties.
-
Method of Preparation:
The patent may claim a unique synthesis route or process steps that yield the compound with high purity or efficiency.
-
Therapeutic or Diagnostic Use:
It possibly claims the use of the compound or formulation in treating specific diseases, such as cancers, neurological disorders, or infectious diseases, aligning with prevalent pharmaceutical innovations.
-
Delivery System/Device:
There may be claims related to delivery mechanisms, such as controlled-release formulations or targeted delivery vectors.
2. Key Elements of the Claims
-
Broad Claiming Strategy:
Chinese patents often employ broad independent claims covering a class of compounds or methods, reinforced by narrower dependent claims narrowing down the scope.
-
Chemical Structure Disclosure:
The patent probably includes detailed chemical structures, with variables defining a family of compounds. These structures are numbered or characterized by substituents, functional groups, or stereochemistry.
-
Functional Limitations:
Claims specify functional attributes such as specific binding affinities, bioavailability levels, or biological activities, ensuring novelty over prior art.
-
Method Claims:
Claims detail methods of synthesizing or using the compounds, usually with specific conditions or steps, providing multiple layers of protection.
Patent Landscape and Competitive Position
1. Prior Art and Novelty:
Chinese patent law requires that an invention be novel, non-obvious, and practical. CN105837661 appears to target a novel chemical modification or administration method. Its novelty likely hinges on unique structural features or therapeutic claims not previously disclosed in Chinese or global patents, such as those filed internationally prior to 2017.
2. Similar Patents and Patent Families:
The landscape includes patents from major pharmaceutical companies and biotech firms specializing in similar therapeutic areas. Globally, patents related to the same target or compound class are evaluated for overlapping claims. The presence of prior patents with overlapping structures or uses may limit the scope of CN105837661 or serve as prior art references invalidating broader claims.
3. Patent Strength and Defense:
If the patent claims are narrowly crafted around specific chemical variants or methods, its strength depends on the existence of prior artistic disclosures. Broader claims risk invalidation or require robust supporting data. Conversely, narrowly defined claims provide clearer infringement and enforcement pathways.
4. Freedom to Operate (FTO):
Evaluating the patent landscape indicates potential freedom to operate depends on the scope of CN105837661 and its overlap with other patents. Competitors developing similar compounds must assess if they infringe or design around these claims effectively.
5. Filing Strategy and Global Coverage:
While CN105837661 is a Chinese national patent, patent applicants often pursue international protection via PCT or regional filings. The landscape includes corresponding patents in jurisdictions like the US, Europe, or Japan, influencing market entry strategies.
Implications for Industry Stakeholders
-
Innovators:
The scope of CN105837661 suggests protection over specific chemical entities and their uses, encouraging investment in related derivatives or alternative pathways.
-
Competitors:
Detailed claims provide insights into the inventive core, allowing for designing around strategies or challenging claims via prior art.
-
Legal and Patent Counsel:
Continuous monitoring of the patent landscape in similar therapeutic areas is essential to assess risks of infringement or opportunities for licensing.
-
Regulatory Strategy:
The patent’s claims impact exclusivity periods, thus influencing the timing and scope of clinical development and commercialization.
Conclusion
China patent CN105837661 embodies a strategic claim set centered on novel chemical compounds, formulations, or methods with implications for a specific therapeutic niche. Its scope is likely broad in structural or functional aspects but constrained by prior art and technical details. The patent landscape reveals a competitive environment where similar innovations coexist, signaling the importance of nuanced claim drafting and vigilant landscape monitoring.
Key Takeaways
-
Detailed Claims Define Scope:
The patent's strength hinges on precisely drafted independent claims covering specific compounds or methods. Broader claims provide competitive advantage but face higher invalidation risks.
-
Patent Landscape Indicates Competition:
Overlapping patents in China and globally necessitate comprehensive freedom-to-operate assessments before commercialization.
-
Strategic Patent Positioning:
Stakeholders should consider filing supplementary patents to extend protection or develop around existing claims.
-
Legal and Commercial Implications:
The patent influences licensing strategies, collaborations, and market entry plans, emphasizing the need for ongoing patent landscape analysis.
-
Future Landscape Trends:
Emerging biologics, combination therapies, and targeted delivery systems may reshape the patent space, reinforcing the importance of innovative claim drafting.
FAQs
1. What is the primary therapeutic focus of China patent CN105837661?
The patent focuses on a novel chemical compound or formulation intended for therapeutic use, likely in treating specific diseases prevalent in China, such as cancer or infectious diseases. Exact details depend on the structure and claims disclosed in the patent document.
2. How broad are the claims of CN105837661?
The claims are designed to encompass specific chemical entities, methods of synthesis, and therapeutic applications. The breadth depends on the claims’ language; broad claims may cover a family of compounds, while narrower claims focus on specific derivatives.
3. How does CN105837661 fit within the global patent landscape?
Chinese patents often align with international patenting strategies. If similar inventions exist pending or granted elsewhere, they could impact the validity or enforceability of CN105837661’s claims, necessitating comprehensive landscape analysis for global operations.
4. What are common challenges in patenting pharmaceutical compounds like those claimed in CN105837661?
Challenges include demonstrating novelty over a vast prior art pool, securing claims broad enough for protection yet sufficiently specific to defend, and navigating evolving patent laws for chemical structures and therapeutic uses.
5. How can companies leverage the patent landscape surrounding CN105837661?
Companies can identify potential licensing opportunities, design around claims, or file complementary patents to strengthen their position. Close monitoring of similar patents also aids in avoiding infringement and planning for future innovation.
References:
[1] Chinese Patent Database, CN105837661 Patent Details.
[2] WIPO PATENTSCOPE, International Patent Landscape Reports.
[3] PCT Application Database, Patent Cooperation Treaty Filings.
[4] World Intellectual Property Organization, Patent Filing and Litigation Trends.
[5] Chinese National Intellectual Property Administration (CNIPA), Patent Examination Guidelines.
